nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—LRRK2—Crohn's disease	0.221	0.397	CbGaD
Sunitinib—TYK2—Crohn's disease	0.167	0.301	CbGaD
Sunitinib—JAK2—Crohn's disease	0.167	0.301	CbGaD
Sunitinib—ABCC4—Mercaptopurine—Crohn's disease	0.0325	0.422	CbGbCtD
Sunitinib—ABCC2—Sulfasalazine—Crohn's disease	0.0158	0.205	CbGbCtD
Sunitinib—ABCG2—Sulfasalazine—Crohn's disease	0.0143	0.185	CbGbCtD
Sunitinib—CYP3A5—Sulfasalazine—Crohn's disease	0.0079	0.103	CbGbCtD
Sunitinib—ABCB1—Prednisone—Crohn's disease	0.00411	0.0534	CbGbCtD
Sunitinib—CYP3A4—Prednisone—Crohn's disease	0.00246	0.032	CbGbCtD
Sunitinib—Procainamide—SLC22A4—Crohn's disease	0.00116	0.571	CrCbGaD
Sunitinib—OXSR1—Methyldopa—Mesalazine—Crohn's disease	0.00107	0.494	CbGdCrCtD
Sunitinib—Procainamide—SLC22A5—Crohn's disease	0.000871	0.429	CrCbGaD
Sunitinib—PRPF4—Methyldopa—Mesalazine—Crohn's disease	0.000596	0.275	CbGdCrCtD
Sunitinib—Protein urine present—Mesalazine—Crohn's disease	0.000412	0.00448	CcSEcCtD
Sunitinib—Skin discolouration—Mesalazine—Crohn's disease	0.000407	0.00442	CcSEcCtD
Sunitinib—Rectal haemorrhage—Mesalazine—Crohn's disease	0.000407	0.00442	CcSEcCtD
Sunitinib—Oropharyngeal pain—Mesalazine—Crohn's disease	0.000404	0.00439	CcSEcCtD
Sunitinib—Pancytopenia—Mercaptopurine—Crohn's disease	0.000403	0.00438	CcSEcCtD
Sunitinib—Hypocalcaemia—Mesalazine—Crohn's disease	0.000401	0.00436	CcSEcCtD
Sunitinib—Blood bilirubin increased—Mesalazine—Crohn's disease	0.000389	0.00422	CcSEcCtD
Sunitinib—Lymphopenia—Prednisone—Crohn's disease	0.00038	0.00412	CcSEcCtD
Sunitinib—Musculoskeletal pain—Mesalazine—Crohn's disease	0.000372	0.00404	CcSEcCtD
Sunitinib—Hypernatraemia—Prednisone—Crohn's disease	0.00037	0.00401	CcSEcCtD
Sunitinib—Stomatitis—Mercaptopurine—Crohn's disease	0.000369	0.00401	CcSEcCtD
Sunitinib—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000368	0.00399	CcSEcCtD
Sunitinib—Neoplasm—Azathioprine—Crohn's disease	0.000365	0.00396	CcSEcCtD
Sunitinib—Eructation—Mesalazine—Crohn's disease	0.000361	0.00392	CcSEcCtD
Sunitinib—Melaena—Mesalazine—Crohn's disease	0.000359	0.0039	CcSEcCtD
Sunitinib—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.000358	0.00389	CcSEcCtD
Sunitinib—Influenza like illness—Mesalazine—Crohn's disease	0.000357	0.00387	CcSEcCtD
Sunitinib—Candida infection—Mesalazine—Crohn's disease	0.000351	0.00381	CcSEcCtD
Sunitinib—Skin exfoliation—Mesalazine—Crohn's disease	0.000351	0.00381	CcSEcCtD
Sunitinib—Hepatic function abnormal—Azathioprine—Crohn's disease	0.000335	0.00364	CcSEcCtD
Sunitinib—Mouth ulceration—Mesalazine—Crohn's disease	0.000332	0.00361	CcSEcCtD
Sunitinib—Hepatic failure—Azathioprine—Crohn's disease	0.000326	0.00354	CcSEcCtD
Sunitinib—Febrile neutropenia—Prednisone—Crohn's disease	0.000323	0.00351	CcSEcCtD
Sunitinib—ALK—digestive system—Crohn's disease	0.000315	0.00296	CbGeAlD
Sunitinib—MAP4K1—lymphoid tissue—Crohn's disease	0.000313	0.00294	CbGeAlD
Sunitinib—MAP4K4—mammalian vulva—Crohn's disease	0.00031	0.00292	CbGeAlD
Sunitinib—PTK2B—smooth muscle tissue—Crohn's disease	0.000309	0.00291	CbGeAlD
Sunitinib—NUAK2—mammalian vulva—Crohn's disease	0.000308	0.00289	CbGeAlD
Sunitinib—Immune system disorder—Mercaptopurine—Crohn's disease	0.000307	0.00333	CcSEcCtD
Sunitinib—PRKAA2—lymph node—Crohn's disease	0.000307	0.00289	CbGeAlD
Sunitinib—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.000307	0.00333	CcSEcCtD
Sunitinib—MAP3K12—mammalian vulva—Crohn's disease	0.000306	0.00287	CbGeAlD
Sunitinib—CLK2—lymphoid tissue—Crohn's disease	0.000304	0.00286	CbGeAlD
Sunitinib—Hypothyroidism—Prednisone—Crohn's disease	0.000303	0.00329	CcSEcCtD
Sunitinib—Embolism—Prednisone—Crohn's disease	0.000303	0.00329	CcSEcCtD
Sunitinib—MAP4K2—lymphoid tissue—Crohn's disease	0.000302	0.00284	CbGeAlD
Sunitinib—RPS6KA3—mammalian vulva—Crohn's disease	0.000301	0.00283	CbGeAlD
Sunitinib—Alopecia—Mercaptopurine—Crohn's disease	0.0003	0.00326	CcSEcCtD
Sunitinib—CSNK1E—skin of body—Crohn's disease	0.0003	0.00282	CbGeAlD
Sunitinib—Eczema—Mesalazine—Crohn's disease	0.000297	0.00322	CcSEcCtD
Sunitinib—Hepatic failure—Mesalazine—Crohn's disease	0.000297	0.00322	CcSEcCtD
Sunitinib—Malnutrition—Mercaptopurine—Crohn's disease	0.000296	0.00321	CcSEcCtD
Sunitinib—STK17B—lymph node—Crohn's disease	0.000296	0.00278	CbGeAlD
Sunitinib—CSNK1A1—mammalian vulva—Crohn's disease	0.000295	0.00278	CbGeAlD
Sunitinib—ROCK1—lymphoid tissue—Crohn's disease	0.000294	0.00277	CbGeAlD
Sunitinib—CLK1—mammalian vulva—Crohn's disease	0.000294	0.00276	CbGeAlD
Sunitinib—MAP2K2—smooth muscle tissue—Crohn's disease	0.000293	0.00275	CbGeAlD
Sunitinib—ROCK1—digestive system—Crohn's disease	0.000291	0.00273	CbGeAlD
Sunitinib—MAP2K2—skin of body—Crohn's disease	0.000289	0.00272	CbGeAlD
Sunitinib—Renal failure acute—Mesalazine—Crohn's disease	0.000289	0.00314	CcSEcCtD
Sunitinib—MAP3K7—smooth muscle tissue—Crohn's disease	0.000288	0.00271	CbGeAlD
Sunitinib—DYRK1A—lymphoid tissue—Crohn's disease	0.000287	0.0027	CbGeAlD
Sunitinib—LRRK2—mammalian vulva—Crohn's disease	0.000286	0.00269	CbGeAlD
Sunitinib—RPS6KB1—epithelium—Crohn's disease	0.000284	0.00267	CbGeAlD
Sunitinib—TYK2—smooth muscle tissue—Crohn's disease	0.000283	0.00266	CbGeAlD
Sunitinib—RET—epithelium—Crohn's disease	0.000282	0.00266	CbGeAlD
Sunitinib—MERTK—lymphoid tissue—Crohn's disease	0.00028	0.00264	CbGeAlD
Sunitinib—Renal impairment—Mesalazine—Crohn's disease	0.00028	0.00304	CcSEcCtD
Sunitinib—Dermatitis bullous—Mesalazine—Crohn's disease	0.000279	0.00303	CcSEcCtD
Sunitinib—TYK2—skin of body—Crohn's disease	0.000279	0.00262	CbGeAlD
Sunitinib—IRAK1—smooth muscle tissue—Crohn's disease	0.000279	0.00262	CbGeAlD
Sunitinib—Myopathy—Prednisone—Crohn's disease	0.000277	0.00301	CcSEcCtD
Sunitinib—MAP4K4—lymphoid tissue—Crohn's disease	0.000275	0.00259	CbGeAlD
Sunitinib—RPS6KB1—smooth muscle tissue—Crohn's disease	0.000274	0.00258	CbGeAlD
Sunitinib—FGFR1—mammalian vulva—Crohn's disease	0.000274	0.00258	CbGeAlD
Sunitinib—CSNK1E—mammalian vulva—Crohn's disease	0.000274	0.00258	CbGeAlD
Sunitinib—Anaemia—Mercaptopurine—Crohn's disease	0.000274	0.00297	CcSEcCtD
Sunitinib—STK17A—lymph node—Crohn's disease	0.000272	0.00256	CbGeAlD
Sunitinib—MAP4K4—digestive system—Crohn's disease	0.000272	0.00256	CbGeAlD
Sunitinib—FLT3—lymphoid tissue—Crohn's disease	0.000271	0.00255	CbGeAlD
Sunitinib—AXL—smooth muscle tissue—Crohn's disease	0.000271	0.00255	CbGeAlD
Sunitinib—IRAK4—mammalian vulva—Crohn's disease	0.00027	0.00253	CbGeAlD
Sunitinib—CDK14—lymph node—Crohn's disease	0.000268	0.00252	CbGeAlD
Sunitinib—FGFR2—epithelium—Crohn's disease	0.000268	0.00252	CbGeAlD
Sunitinib—RPS6KA3—lymphoid tissue—Crohn's disease	0.000268	0.00252	CbGeAlD
Sunitinib—AXL—skin of body—Crohn's disease	0.000268	0.00252	CbGeAlD
Sunitinib—JAK2—epithelium—Crohn's disease	0.000267	0.00251	CbGeAlD
Sunitinib—MAP2K1—lymphoid tissue—Crohn's disease	0.000266	0.0025	CbGeAlD
Sunitinib—Leukopenia—Mercaptopurine—Crohn's disease	0.000265	0.00288	CcSEcCtD
Sunitinib—PAK3—lymph node—Crohn's disease	0.000265	0.00249	CbGeAlD
Sunitinib—LATS2—lymph node—Crohn's disease	0.000265	0.00249	CbGeAlD
Sunitinib—CDK16—lymph node—Crohn's disease	0.000265	0.00249	CbGeAlD
Sunitinib—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.000264	0.00286	CcSEcCtD
Sunitinib—MAP2K2—mammalian vulva—Crohn's disease	0.000264	0.00248	CbGeAlD
Sunitinib—ULK3—mammalian vulva—Crohn's disease	0.000264	0.00248	CbGeAlD
Sunitinib—MAP2K1—digestive system—Crohn's disease	0.000263	0.00247	CbGeAlD
Sunitinib—CSNK1A1—lymphoid tissue—Crohn's disease	0.000262	0.00247	CbGeAlD
Sunitinib—RPS6KA5—lymph node—Crohn's disease	0.000261	0.00246	CbGeAlD
Sunitinib—CLK1—lymphoid tissue—Crohn's disease	0.000261	0.00245	CbGeAlD
Sunitinib—MAP3K7—mammalian vulva—Crohn's disease	0.000259	0.00244	CbGeAlD
Sunitinib—CSNK1A1—digestive system—Crohn's disease	0.000259	0.00244	CbGeAlD
Sunitinib—FGFR2—smooth muscle tissue—Crohn's disease	0.000259	0.00243	CbGeAlD
Sunitinib—Face oedema—Mesalazine—Crohn's disease	0.000258	0.0028	CcSEcCtD
Sunitinib—CLK1—digestive system—Crohn's disease	0.000257	0.00242	CbGeAlD
Sunitinib—JAK2—smooth muscle tissue—Crohn's disease	0.000257	0.00242	CbGeAlD
Sunitinib—TBK1—mammalian vulva—Crohn's disease	0.000256	0.00241	CbGeAlD
Sunitinib—FGFR2—skin of body—Crohn's disease	0.000255	0.0024	CbGeAlD
Sunitinib—TYK2—mammalian vulva—Crohn's disease	0.000255	0.00239	CbGeAlD
Sunitinib—JAK2—skin of body—Crohn's disease	0.000254	0.00239	CbGeAlD
Sunitinib—FYN—smooth muscle tissue—Crohn's disease	0.000254	0.00239	CbGeAlD
Sunitinib—CAMK2G—digestive system—Crohn's disease	0.000253	0.00238	CbGeAlD
Sunitinib—Arthralgia—Mercaptopurine—Crohn's disease	0.000252	0.00274	CcSEcCtD
Sunitinib—Fungal infection—Prednisone—Crohn's disease	0.000252	0.00273	CcSEcCtD
Sunitinib—CLK4—lymph node—Crohn's disease	0.000251	0.00236	CbGeAlD
Sunitinib—IRAK1—mammalian vulva—Crohn's disease	0.000251	0.00236	CbGeAlD
Sunitinib—FYN—skin of body—Crohn's disease	0.00025	0.00236	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00025	0.00272	CcSEcCtD
Sunitinib—Blood creatinine increased—Mesalazine—Crohn's disease	0.00025	0.00271	CcSEcCtD
Sunitinib—PRKAA1—lymphoid tissue—Crohn's disease	0.00025	0.00235	CbGeAlD
Sunitinib—FLT1—epithelium—Crohn's disease	0.000249	0.00234	CbGeAlD
Sunitinib—SBK1—lymph node—Crohn's disease	0.000248	0.00234	CbGeAlD
Sunitinib—ITK—lymph node—Crohn's disease	0.000248	0.00234	CbGeAlD
Sunitinib—Pancreatitis—Azathioprine—Crohn's disease	0.000248	0.00269	CcSEcCtD
Sunitinib—MAP4K5—smooth muscle tissue—Crohn's disease	0.000248	0.00233	CbGeAlD
Sunitinib—PTK2B—lymphoid tissue—Crohn's disease	0.000247	0.00232	CbGeAlD
Sunitinib—PRKAA1—digestive system—Crohn's disease	0.000247	0.00232	CbGeAlD
Sunitinib—RPS6KB1—mammalian vulva—Crohn's disease	0.000247	0.00232	CbGeAlD
Sunitinib—FLT4—lymphoid tissue—Crohn's disease	0.000246	0.00232	CbGeAlD
Sunitinib—Liver function test abnormal—Mesalazine—Crohn's disease	0.000246	0.00267	CcSEcCtD
Sunitinib—Abscess—Prednisone—Crohn's disease	0.000246	0.00267	CcSEcCtD
Sunitinib—BLK—lymph node—Crohn's disease	0.000246	0.00231	CbGeAlD
Sunitinib—FGR—mammalian vulva—Crohn's disease	0.000245	0.0023	CbGeAlD
Sunitinib—MAP3K3—skin of body—Crohn's disease	0.000245	0.0023	CbGeAlD
Sunitinib—Dry skin—Mesalazine—Crohn's disease	0.000245	0.00265	CcSEcCtD
Sunitinib—PTK2B—digestive system—Crohn's disease	0.000244	0.0023	CbGeAlD
Sunitinib—AXL—mammalian vulva—Crohn's disease	0.000244	0.0023	CbGeAlD
Sunitinib—Abdominal pain upper—Mesalazine—Crohn's disease	0.000244	0.00265	CcSEcCtD
Sunitinib—PHKG1—lymph node—Crohn's disease	0.000243	0.00228	CbGeAlD
Sunitinib—DAPK1—lymph node—Crohn's disease	0.000243	0.00228	CbGeAlD
Sunitinib—Abdominal discomfort—Azathioprine—Crohn's disease	0.000243	0.00263	CcSEcCtD
Sunitinib—Oedema—Mercaptopurine—Crohn's disease	0.000242	0.00262	CcSEcCtD
Sunitinib—Pancytopenia—Azathioprine—Crohn's disease	0.00024	0.00261	CcSEcCtD
Sunitinib—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00024	0.00261	CcSEcCtD
Sunitinib—CSNK1E—digestive system—Crohn's disease	0.00024	0.00226	CbGeAlD
Sunitinib—FLT1—smooth muscle tissue—Crohn's disease	0.00024	0.00225	CbGeAlD
Sunitinib—IRAK4—lymphoid tissue—Crohn's disease	0.000239	0.00225	CbGeAlD
Sunitinib—Nasopharyngitis—Mesalazine—Crohn's disease	0.000239	0.00259	CcSEcCtD
Sunitinib—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000237	0.00257	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.000235	0.00255	CcSEcCtD
Sunitinib—STK11—lymph node—Crohn's disease	0.000235	0.00221	CbGeAlD
Sunitinib—BRD4—lymph node—Crohn's disease	0.000235	0.00221	CbGeAlD
Sunitinib—SLK—mammalian vulva—Crohn's disease	0.000235	0.00221	CbGeAlD
Sunitinib—Skin disorder—Mercaptopurine—Crohn's disease	0.000235	0.00255	CcSEcCtD
Sunitinib—Endocrine disorder—Prednisone—Crohn's disease	0.000235	0.00255	CcSEcCtD
Sunitinib—MAP2K2—lymphoid tissue—Crohn's disease	0.000234	0.0022	CbGeAlD
Sunitinib—EPHB6—skin of body—Crohn's disease	0.000234	0.0022	CbGeAlD
Sunitinib—RIOK1—lymph node—Crohn's disease	0.000233	0.00219	CbGeAlD
Sunitinib—RPS6KA1—lymph node—Crohn's disease	0.000233	0.00219	CbGeAlD
Sunitinib—MAP3K2—lymphoid tissue—Crohn's disease	0.000232	0.00219	CbGeAlD
Sunitinib—Abdominal distension—Mesalazine—Crohn's disease	0.000232	0.00252	CcSEcCtD
Sunitinib—JAK2—mammalian vulva—Crohn's disease	0.000232	0.00218	CbGeAlD
Sunitinib—MAP2K2—digestive system—Crohn's disease	0.000231	0.00217	CbGeAlD
Sunitinib—ULK3—digestive system—Crohn's disease	0.000231	0.00217	CbGeAlD
Sunitinib—Acne—Prednisone—Crohn's disease	0.000231	0.00251	CcSEcCtD
Sunitinib—Dysphagia—Mesalazine—Crohn's disease	0.000231	0.0025	CcSEcCtD
Sunitinib—Anorexia—Mercaptopurine—Crohn's disease	0.00023	0.0025	CcSEcCtD
Sunitinib—YES1—smooth muscle tissue—Crohn's disease	0.000229	0.00215	CbGeAlD
Sunitinib—FYN—mammalian vulva—Crohn's disease	0.000228	0.00215	CbGeAlD
Sunitinib—MARK2—lymph node—Crohn's disease	0.000228	0.00215	CbGeAlD
Sunitinib—TNIK—lymph node—Crohn's disease	0.000228	0.00215	CbGeAlD
Sunitinib—TBK1—lymphoid tissue—Crohn's disease	0.000228	0.00214	CbGeAlD
Sunitinib—Pneumonia—Azathioprine—Crohn's disease	0.000227	0.00246	CcSEcCtD
Sunitinib—SGK3—lymph node—Crohn's disease	0.000226	0.00213	CbGeAlD
Sunitinib—Pancreatitis—Mesalazine—Crohn's disease	0.000226	0.00245	CcSEcCtD
Sunitinib—TYK2—lymphoid tissue—Crohn's disease	0.000226	0.00213	CbGeAlD
Sunitinib—Infestation NOS—Azathioprine—Crohn's disease	0.000226	0.00245	CcSEcCtD
Sunitinib—Infestation—Azathioprine—Crohn's disease	0.000226	0.00245	CcSEcCtD
Sunitinib—TBK1—digestive system—Crohn's disease	0.000225	0.00211	CbGeAlD
Sunitinib—PDGFRA—smooth muscle tissue—Crohn's disease	0.000225	0.00211	CbGeAlD
Sunitinib—ICK—lymph node—Crohn's disease	0.000224	0.00211	CbGeAlD
Sunitinib—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.000224	0.00243	CcSEcCtD
Sunitinib—TYK2—digestive system—Crohn's disease	0.000223	0.0021	CbGeAlD
Sunitinib—MAP4K5—mammalian vulva—Crohn's disease	0.000223	0.0021	CbGeAlD
Sunitinib—MAP3K3—mammalian vulva—Crohn's disease	0.000223	0.0021	CbGeAlD
Sunitinib—Bronchitis—Mesalazine—Crohn's disease	0.000222	0.00241	CcSEcCtD
Sunitinib—Abdominal discomfort—Mesalazine—Crohn's disease	0.000221	0.0024	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00022	0.00239	CcSEcCtD
Sunitinib—Pancytopenia—Mesalazine—Crohn's disease	0.000219	0.00238	CcSEcCtD
Sunitinib—RPS6KB1—lymphoid tissue—Crohn's disease	0.000219	0.00206	CbGeAlD
Sunitinib—FGR—lymphoid tissue—Crohn's disease	0.000218	0.00205	CbGeAlD
Sunitinib—RET—lymphoid tissue—Crohn's disease	0.000218	0.00205	CbGeAlD
Sunitinib—AXL—lymphoid tissue—Crohn's disease	0.000217	0.00204	CbGeAlD
Sunitinib—CHEK2—lymph node—Crohn's disease	0.000216	0.00203	CbGeAlD
Sunitinib—NUAK1—lymph node—Crohn's disease	0.000216	0.00203	CbGeAlD
Sunitinib—RPS6KB1—digestive system—Crohn's disease	0.000216	0.00203	CbGeAlD
Sunitinib—FLT1—mammalian vulva—Crohn's disease	0.000216	0.00203	CbGeAlD
Sunitinib—Neutropenia—Mesalazine—Crohn's disease	0.000216	0.00234	CcSEcCtD
Sunitinib—Viral infection—Prednisone—Crohn's disease	0.000215	0.00234	CcSEcCtD
Sunitinib—RET—digestive system—Crohn's disease	0.000215	0.00202	CbGeAlD
Sunitinib—FGR—digestive system—Crohn's disease	0.000215	0.00202	CbGeAlD
Sunitinib—SNRK—lymph node—Crohn's disease	0.000215	0.00202	CbGeAlD
Sunitinib—OXSR1—lymph node—Crohn's disease	0.000215	0.00202	CbGeAlD
Sunitinib—INSR—lymph node—Crohn's disease	0.000215	0.00202	CbGeAlD
Sunitinib—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.000214	0.00233	CcSEcCtD
Sunitinib—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000213	0.00232	CcSEcCtD
Sunitinib—EPHB6—mammalian vulva—Crohn's disease	0.000213	0.00201	CbGeAlD
Sunitinib—STK38—lymph node—Crohn's disease	0.000211	0.00199	CbGeAlD
Sunitinib—RPS6KA2—lymph node—Crohn's disease	0.000211	0.00199	CbGeAlD
Sunitinib—KDR—epithelium—Crohn's disease	0.00021	0.00198	CbGeAlD
Sunitinib—Decreased appetite—Mercaptopurine—Crohn's disease	0.00021	0.00228	CcSEcCtD
Sunitinib—AURKC—lymph node—Crohn's disease	0.00021	0.00197	CbGeAlD
Sunitinib—Weight decreased—Mesalazine—Crohn's disease	0.000209	0.00226	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000209	0.00226	CcSEcCtD
Sunitinib—PKN1—lymph node—Crohn's disease	0.000208	0.00196	CbGeAlD
Sunitinib—CSNK1G2—lymph node—Crohn's disease	0.000208	0.00196	CbGeAlD
Sunitinib—Pneumonia—Mesalazine—Crohn's disease	0.000207	0.00224	CcSEcCtD
Sunitinib—YES1—mammalian vulva—Crohn's disease	0.000206	0.00194	CbGeAlD
Sunitinib—JAK2—lymphoid tissue—Crohn's disease	0.000206	0.00193	CbGeAlD
Sunitinib—Infestation NOS—Mesalazine—Crohn's disease	0.000206	0.00223	CcSEcCtD
Sunitinib—Infestation—Mesalazine—Crohn's disease	0.000206	0.00223	CcSEcCtD
Sunitinib—Depression—Mesalazine—Crohn's disease	0.000205	0.00223	CcSEcCtD
Sunitinib—PRPF4—lymph node—Crohn's disease	0.000205	0.00193	CbGeAlD
Sunitinib—STK10—mammalian vulva—Crohn's disease	0.000204	0.00192	CbGeAlD
Sunitinib—FGFR2—digestive system—Crohn's disease	0.000204	0.00192	CbGeAlD
Sunitinib—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.000204	0.00221	CcSEcCtD
Sunitinib—Haemoglobin—Azathioprine—Crohn's disease	0.000204	0.00221	CcSEcCtD
Sunitinib—TAOK3—mammalian vulva—Crohn's disease	0.000203	0.00191	CbGeAlD
Sunitinib—JAK2—digestive system—Crohn's disease	0.000203	0.00191	CbGeAlD
Sunitinib—FYN—lymphoid tissue—Crohn's disease	0.000203	0.00191	CbGeAlD
Sunitinib—KDR—smooth muscle tissue—Crohn's disease	0.000203	0.00191	CbGeAlD
Sunitinib—Haemorrhage—Azathioprine—Crohn's disease	0.000203	0.0022	CcSEcCtD
Sunitinib—Renal failure—Mesalazine—Crohn's disease	0.000202	0.00219	CcSEcCtD
Sunitinib—PRPF4B—lymph node—Crohn's disease	0.000202	0.0019	CbGeAlD
Sunitinib—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000202	0.00219	CcSEcCtD
Sunitinib—Stomatitis—Mesalazine—Crohn's disease	0.0002	0.00218	CcSEcCtD
Sunitinib—FYN—digestive system—Crohn's disease	0.0002	0.00188	CbGeAlD
Sunitinib—Urinary tract infection—Mesalazine—Crohn's disease	0.0002	0.00217	CcSEcCtD
Sunitinib—STK39—lymph node—Crohn's disease	0.000199	0.00187	CbGeAlD
Sunitinib—MAP4K5—lymphoid tissue—Crohn's disease	0.000198	0.00186	CbGeAlD
Sunitinib—CSF1R—smooth muscle tissue—Crohn's disease	0.000198	0.00186	CbGeAlD
Sunitinib—CSNK2A1—lymph node—Crohn's disease	0.000197	0.00185	CbGeAlD
Sunitinib—CSF1R—skin of body—Crohn's disease	0.000195	0.00184	CbGeAlD
Sunitinib—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000194	0.00211	CcSEcCtD
Sunitinib—MYLK—lymph node—Crohn's disease	0.000194	0.00183	CbGeAlD
Sunitinib—Epistaxis—Mesalazine—Crohn's disease	0.000194	0.00211	CcSEcCtD
Sunitinib—PLK4—lymph node—Crohn's disease	0.000192	0.0018	CbGeAlD
Sunitinib—FLT1—lymphoid tissue—Crohn's disease	0.000192	0.0018	CbGeAlD
Sunitinib—Erythema multiforme—Azathioprine—Crohn's disease	0.000192	0.00208	CcSEcCtD
Sunitinib—Body temperature increased—Mercaptopurine—Crohn's disease	0.000191	0.00207	CcSEcCtD
Sunitinib—STK4—lymph node—Crohn's disease	0.00019	0.00179	CbGeAlD
Sunitinib—FLT1—digestive system—Crohn's disease	0.000189	0.00178	CbGeAlD
Sunitinib—PHKG2—lymph node—Crohn's disease	0.000187	0.00176	CbGeAlD
Sunitinib—KIT—epithelium—Crohn's disease	0.000186	0.00175	CbGeAlD
Sunitinib—STK24—lymph node—Crohn's disease	0.000186	0.00175	CbGeAlD
Sunitinib—Skin exfoliation—Prednisone—Crohn's disease	0.000186	0.00202	CcSEcCtD
Sunitinib—Haemoglobin—Mesalazine—Crohn's disease	0.000185	0.00201	CcSEcCtD
Sunitinib—Haemorrhage—Mesalazine—Crohn's disease	0.000185	0.002	CcSEcCtD
Sunitinib—Hepatitis—Mesalazine—Crohn's disease	0.000185	0.002	CcSEcCtD
Sunitinib—DAPK2—lymph node—Crohn's disease	0.000184	0.00173	CbGeAlD
Sunitinib—YES1—lymphoid tissue—Crohn's disease	0.000183	0.00172	CbGeAlD
Sunitinib—Immune system disorder—Azathioprine—Crohn's disease	0.000183	0.00199	CcSEcCtD
Sunitinib—Mediastinal disorder—Azathioprine—Crohn's disease	0.000183	0.00198	CcSEcCtD
Sunitinib—KDR—mammalian vulva—Crohn's disease	0.000182	0.00172	CbGeAlD
Sunitinib—MAP2K5—mammalian vulva—Crohn's disease	0.000182	0.00172	CbGeAlD
Sunitinib—Urinary tract disorder—Mesalazine—Crohn's disease	0.000182	0.00198	CcSEcCtD
Sunitinib—PDGFRB—epithelium—Crohn's disease	0.000182	0.00171	CbGeAlD
Sunitinib—Oedema peripheral—Mesalazine—Crohn's disease	0.000182	0.00197	CcSEcCtD
Sunitinib—Chills—Azathioprine—Crohn's disease	0.000182	0.00197	CcSEcCtD
Sunitinib—STK10—lymphoid tissue—Crohn's disease	0.000181	0.00171	CbGeAlD
Sunitinib—Connective tissue disorder—Mesalazine—Crohn's disease	0.000181	0.00197	CcSEcCtD
Sunitinib—Arrhythmia—Azathioprine—Crohn's disease	0.000181	0.00196	CcSEcCtD
Sunitinib—STK16—lymph node—Crohn's disease	0.000181	0.0017	CbGeAlD
Sunitinib—Urethral disorder—Mesalazine—Crohn's disease	0.000181	0.00196	CcSEcCtD
Sunitinib—YES1—digestive system—Crohn's disease	0.000181	0.0017	CbGeAlD
Sunitinib—TAOK3—lymphoid tissue—Crohn's disease	0.000181	0.0017	CbGeAlD
Sunitinib—HIPK3—lymph node—Crohn's disease	0.00018	0.00169	CbGeAlD
Sunitinib—HIPK2—lymph node—Crohn's disease	0.00018	0.00169	CbGeAlD
Sunitinib—ALK—lymph node—Crohn's disease	0.00018	0.00169	CbGeAlD
Sunitinib—CSNK1E—Danazol—Prednisone—Crohn's disease	0.00018	0.0829	CbGdCrCtD
Sunitinib—KIT—smooth muscle tissue—Crohn's disease	0.00018	0.00169	CbGeAlD
Sunitinib—PDGFRA—lymphoid tissue—Crohn's disease	0.00018	0.00169	CbGeAlD
Sunitinib—STK10—digestive system—Crohn's disease	0.000179	0.00168	CbGeAlD
Sunitinib—Alopecia—Azathioprine—Crohn's disease	0.000179	0.00194	CcSEcCtD
Sunitinib—TAOK3—digestive system—Crohn's disease	0.000178	0.00168	CbGeAlD
Sunitinib—TNK1—lymph node—Crohn's disease	0.000178	0.00168	CbGeAlD
Sunitinib—RIOK2—lymph node—Crohn's disease	0.000178	0.00168	CbGeAlD
Sunitinib—CSF1R—mammalian vulva—Crohn's disease	0.000178	0.00167	CbGeAlD
Sunitinib—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000178	0.00193	CcSEcCtD
Sunitinib—Oesophagitis—Prednisone—Crohn's disease	0.000178	0.00193	CcSEcCtD
Sunitinib—PDGFRA—digestive system—Crohn's disease	0.000177	0.00167	CbGeAlD
Sunitinib—KIT—skin of body—Crohn's disease	0.000177	0.00167	CbGeAlD
Sunitinib—MAP4K1—lymph node—Crohn's disease	0.000176	0.00166	CbGeAlD
Sunitinib—PDGFRB—smooth muscle tissue—Crohn's disease	0.000175	0.00165	CbGeAlD
Sunitinib—Erythema multiforme—Mesalazine—Crohn's disease	0.000174	0.00189	CcSEcCtD
Sunitinib—PDGFRB—skin of body—Crohn's disease	0.000173	0.00163	CbGeAlD
Sunitinib—Pulmonary oedema—Prednisone—Crohn's disease	0.000173	0.00188	CcSEcCtD
Sunitinib—DAPK3—lymph node—Crohn's disease	0.000173	0.00163	CbGeAlD
Sunitinib—Eye disorder—Mesalazine—Crohn's disease	0.000172	0.00187	CcSEcCtD
Sunitinib—CLK2—lymph node—Crohn's disease	0.000171	0.00161	CbGeAlD
Sunitinib—Cardiac disorder—Mesalazine—Crohn's disease	0.000171	0.00186	CcSEcCtD
Sunitinib—MAP4K2—lymph node—Crohn's disease	0.000171	0.0016	CbGeAlD
Sunitinib—Sepsis—Prednisone—Crohn's disease	0.000169	0.00183	CcSEcCtD
Sunitinib—STK3—lymph node—Crohn's disease	0.000168	0.00158	CbGeAlD
Sunitinib—Angiopathy—Mesalazine—Crohn's disease	0.000167	0.00182	CcSEcCtD
Sunitinib—Immune system disorder—Mesalazine—Crohn's disease	0.000167	0.00181	CcSEcCtD
Sunitinib—Mediastinal disorder—Mesalazine—Crohn's disease	0.000166	0.00181	CcSEcCtD
Sunitinib—Chills—Mesalazine—Crohn's disease	0.000166	0.0018	CcSEcCtD
Sunitinib—Diarrhoea—Mercaptopurine—Crohn's disease	0.000165	0.00179	CcSEcCtD
Sunitinib—Alopecia—Mesalazine—Crohn's disease	0.000163	0.00177	CcSEcCtD
Sunitinib—Anaemia—Azathioprine—Crohn's disease	0.000163	0.00177	CcSEcCtD
Sunitinib—KDR—lymphoid tissue—Crohn's disease	0.000162	0.00152	CbGeAlD
Sunitinib—DYRK1A—lymph node—Crohn's disease	0.000162	0.00152	CbGeAlD
Sunitinib—Mental disorder—Mesalazine—Crohn's disease	0.000162	0.00176	CcSEcCtD
Sunitinib—KIT—mammalian vulva—Crohn's disease	0.000162	0.00152	CbGeAlD
Sunitinib—Erythema—Mesalazine—Crohn's disease	0.000161	0.00174	CcSEcCtD
Sunitinib—KDR—digestive system—Crohn's disease	0.00016	0.0015	CbGeAlD
Sunitinib—Flatulence—Mesalazine—Crohn's disease	0.000158	0.00172	CcSEcCtD
Sunitinib—MERTK—lymph node—Crohn's disease	0.000158	0.00149	CbGeAlD
Sunitinib—CSF1R—lymphoid tissue—Crohn's disease	0.000158	0.00149	CbGeAlD
Sunitinib—PDGFRB—mammalian vulva—Crohn's disease	0.000158	0.00148	CbGeAlD
Sunitinib—Leukopenia—Azathioprine—Crohn's disease	0.000158	0.00171	CcSEcCtD
Sunitinib—Dysgeusia—Mesalazine—Crohn's disease	0.000157	0.00171	CcSEcCtD
Sunitinib—CSF1R—digestive system—Crohn's disease	0.000156	0.00147	CbGeAlD
Sunitinib—Cardiac failure congestive—Prednisone—Crohn's disease	0.000156	0.00169	CcSEcCtD
Sunitinib—Back pain—Mesalazine—Crohn's disease	0.000155	0.00169	CcSEcCtD
Sunitinib—MAP4K4—lymph node—Crohn's disease	0.000155	0.00146	CbGeAlD
Sunitinib—Muscle spasms—Mesalazine—Crohn's disease	0.000154	0.00168	CcSEcCtD
Sunitinib—NUAK2—lymph node—Crohn's disease	0.000154	0.00145	CbGeAlD
Sunitinib—Vomiting—Mercaptopurine—Crohn's disease	0.000154	0.00167	CcSEcCtD
Sunitinib—MAP3K12—lymph node—Crohn's disease	0.000153	0.00144	CbGeAlD
Sunitinib—FLT3—lymph node—Crohn's disease	0.000153	0.00144	CbGeAlD
Sunitinib—Rash—Mercaptopurine—Crohn's disease	0.000152	0.00165	CcSEcCtD
Sunitinib—Dermatitis—Mercaptopurine—Crohn's disease	0.000152	0.00165	CcSEcCtD
Sunitinib—RPS6KA3—lymph node—Crohn's disease	0.000151	0.00142	CbGeAlD
Sunitinib—Myalgia—Azathioprine—Crohn's disease	0.00015	0.00163	CcSEcCtD
Sunitinib—Arthralgia—Azathioprine—Crohn's disease	0.00015	0.00163	CcSEcCtD
Sunitinib—MAP2K1—lymph node—Crohn's disease	0.00015	0.00141	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000149	0.00162	CcSEcCtD
Sunitinib—Anaemia—Mesalazine—Crohn's disease	0.000148	0.00161	CcSEcCtD
Sunitinib—CSNK1A1—lymph node—Crohn's disease	0.000148	0.00139	CbGeAlD
Sunitinib—CLK1—lymph node—Crohn's disease	0.000147	0.00138	CbGeAlD
Sunitinib—Angioedema—Mesalazine—Crohn's disease	0.000147	0.00159	CcSEcCtD
Sunitinib—Cardiac failure—Prednisone—Crohn's disease	0.000145	0.00157	CcSEcCtD
Sunitinib—CAMK2G—lymph node—Crohn's disease	0.000144	0.00136	CbGeAlD
Sunitinib—BMP2K—lymph node—Crohn's disease	0.000144	0.00136	CbGeAlD
Sunitinib—Leukopenia—Mesalazine—Crohn's disease	0.000144	0.00156	CcSEcCtD
Sunitinib—KIT—lymphoid tissue—Crohn's disease	0.000144	0.00135	CbGeAlD
Sunitinib—Nausea—Mercaptopurine—Crohn's disease	0.000143	0.00156	CcSEcCtD
Sunitinib—LRRK2—lymph node—Crohn's disease	0.000143	0.00135	CbGeAlD
Sunitinib—Infection—Azathioprine—Crohn's disease	0.000143	0.00155	CcSEcCtD
Sunitinib—KIT—digestive system—Crohn's disease	0.000142	0.00133	CbGeAlD
Sunitinib—PRKAA1—lymph node—Crohn's disease	0.000141	0.00133	CbGeAlD
Sunitinib—Thrombocytopenia—Azathioprine—Crohn's disease	0.000141	0.00153	CcSEcCtD
Sunitinib—Cough—Mesalazine—Crohn's disease	0.00014	0.00152	CcSEcCtD
Sunitinib—PDGFRB—lymphoid tissue—Crohn's disease	0.00014	0.00132	CbGeAlD
Sunitinib—Skin disorder—Azathioprine—Crohn's disease	0.00014	0.00152	CcSEcCtD
Sunitinib—PTK2B—lymph node—Crohn's disease	0.000139	0.00131	CbGeAlD
Sunitinib—FLT4—lymph node—Crohn's disease	0.000139	0.00131	CbGeAlD
Sunitinib—Hypertension—Mesalazine—Crohn's disease	0.000139	0.00151	CcSEcCtD
Sunitinib—PDGFRB—digestive system—Crohn's disease	0.000138	0.0013	CbGeAlD
Sunitinib—CSNK1E—lymph node—Crohn's disease	0.000137	0.00129	CbGeAlD
Sunitinib—FGFR1—lymph node—Crohn's disease	0.000137	0.00129	CbGeAlD
Sunitinib—Chest pain—Mesalazine—Crohn's disease	0.000137	0.00148	CcSEcCtD
Sunitinib—Arthralgia—Mesalazine—Crohn's disease	0.000137	0.00148	CcSEcCtD
Sunitinib—Myalgia—Mesalazine—Crohn's disease	0.000137	0.00148	CcSEcCtD
Sunitinib—Face oedema—Prednisone—Crohn's disease	0.000136	0.00148	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000136	0.00147	CcSEcCtD
Sunitinib—IRAK4—lymph node—Crohn's disease	0.000135	0.00127	CbGeAlD
Sunitinib—Dry mouth—Mesalazine—Crohn's disease	0.000134	0.00145	CcSEcCtD
Sunitinib—MAP2K2—lymph node—Crohn's disease	0.000132	0.00124	CbGeAlD
Sunitinib—ULK3—lymph node—Crohn's disease	0.000132	0.00124	CbGeAlD
Sunitinib—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000131	0.00142	CcSEcCtD
Sunitinib—Oedema—Mesalazine—Crohn's disease	0.000131	0.00142	CcSEcCtD
Sunitinib—MAP3K2—lymph node—Crohn's disease	0.000131	0.00123	CbGeAlD
Sunitinib—Infection—Mesalazine—Crohn's disease	0.00013	0.00141	CcSEcCtD
Sunitinib—MAP3K7—lymph node—Crohn's disease	0.00013	0.00122	CbGeAlD
Sunitinib—Dry skin—Prednisone—Crohn's disease	0.000129	0.0014	CcSEcCtD
Sunitinib—Shock—Mesalazine—Crohn's disease	0.000129	0.0014	CcSEcCtD
Sunitinib—Nervous system disorder—Mesalazine—Crohn's disease	0.000129	0.0014	CcSEcCtD
Sunitinib—Hypokalaemia—Prednisone—Crohn's disease	0.000128	0.00139	CcSEcCtD
Sunitinib—TBK1—lymph node—Crohn's disease	0.000128	0.00121	CbGeAlD
Sunitinib—Thrombocytopenia—Mesalazine—Crohn's disease	0.000128	0.00139	CcSEcCtD
Sunitinib—TYK2—lymph node—Crohn's disease	0.000128	0.0012	CbGeAlD
Sunitinib—Skin disorder—Mesalazine—Crohn's disease	0.000127	0.00138	CcSEcCtD
Sunitinib—IRAK1—lymph node—Crohn's disease	0.000126	0.00118	CbGeAlD
Sunitinib—Anorexia—Mesalazine—Crohn's disease	0.000125	0.00136	CcSEcCtD
Sunitinib—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000124	0.00135	CcSEcCtD
Sunitinib—Muscular weakness—Prednisone—Crohn's disease	0.000124	0.00135	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000124	0.00135	CcSEcCtD
Sunitinib—RPS6KB1—lymph node—Crohn's disease	0.000123	0.00116	CbGeAlD
Sunitinib—Abdominal distension—Prednisone—Crohn's disease	0.000123	0.00133	CcSEcCtD
Sunitinib—RET—lymph node—Crohn's disease	0.000123	0.00115	CbGeAlD
Sunitinib—FGR—lymph node—Crohn's disease	0.000123	0.00115	CbGeAlD
Sunitinib—AXL—lymph node—Crohn's disease	0.000122	0.00115	CbGeAlD
Sunitinib—Pancreatitis—Prednisone—Crohn's disease	0.00012	0.0013	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000119	0.0013	CcSEcCtD
Sunitinib—Insomnia—Mesalazine—Crohn's disease	0.000119	0.00129	CcSEcCtD
Sunitinib—Paraesthesia—Mesalazine—Crohn's disease	0.000118	0.00128	CcSEcCtD
Sunitinib—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000118	0.00128	CcSEcCtD
Sunitinib—SLK—lymph node—Crohn's disease	0.000118	0.00111	CbGeAlD
Sunitinib—Dyspnoea—Mesalazine—Crohn's disease	0.000117	0.00127	CcSEcCtD
Sunitinib—JAK2—lymph node—Crohn's disease	0.000116	0.00109	CbGeAlD
Sunitinib—Dyspepsia—Mesalazine—Crohn's disease	0.000115	0.00125	CcSEcCtD
Sunitinib—CSNK1E—Betamethasone—Prednisone—Crohn's disease	0.000115	0.0529	CbGdCrCtD
Sunitinib—CSNK1E—Dexamethasone—Prednisone—Crohn's disease	0.000115	0.0529	CbGdCrCtD
Sunitinib—FYN—lymph node—Crohn's disease	0.000114	0.00108	CbGeAlD
Sunitinib—Neutropenia—Prednisone—Crohn's disease	0.000114	0.00124	CcSEcCtD
Sunitinib—Decreased appetite—Mesalazine—Crohn's disease	0.000114	0.00124	CcSEcCtD
Sunitinib—Body temperature increased—Azathioprine—Crohn's disease	0.000114	0.00124	CcSEcCtD
Sunitinib—Abdominal pain—Azathioprine—Crohn's disease	0.000114	0.00124	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000113	0.00123	CcSEcCtD
Sunitinib—Fatigue—Mesalazine—Crohn's disease	0.000113	0.00123	CcSEcCtD
Sunitinib—Constipation—Mesalazine—Crohn's disease	0.000112	0.00122	CcSEcCtD
Sunitinib—Pain—Mesalazine—Crohn's disease	0.000112	0.00122	CcSEcCtD
Sunitinib—MAP4K5—lymph node—Crohn's disease	0.000112	0.00105	CbGeAlD
Sunitinib—MAP3K3—lymph node—Crohn's disease	0.000112	0.00105	CbGeAlD
Sunitinib—Weight decreased—Prednisone—Crohn's disease	0.00011	0.0012	CcSEcCtD
Sunitinib—ABCC4—digestive system—Crohn's disease	0.00011	0.00104	CbGeAlD
Sunitinib—Hyperglycaemia—Prednisone—Crohn's disease	0.00011	0.00119	CcSEcCtD
Sunitinib—Depression—Prednisone—Crohn's disease	0.000108	0.00118	CcSEcCtD
Sunitinib—FLT1—lymph node—Crohn's disease	0.000108	0.00102	CbGeAlD
Sunitinib—Acute coronary syndrome—Prednisone—Crohn's disease	0.000107	0.00116	CcSEcCtD
Sunitinib—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000107	0.00116	CcSEcCtD
Sunitinib—EPHB6—lymph node—Crohn's disease	0.000107	0.001	CbGeAlD
Sunitinib—ABCC2—digestive system—Crohn's disease	0.000107	0.001	CbGeAlD
Sunitinib—Neuropathy peripheral—Prednisone—Crohn's disease	0.000107	0.00116	CcSEcCtD
Sunitinib—Hypersensitivity—Azathioprine—Crohn's disease	0.000106	0.00115	CcSEcCtD
Sunitinib—Body temperature increased—Mesalazine—Crohn's disease	0.000104	0.00113	CcSEcCtD
Sunitinib—Abdominal pain—Mesalazine—Crohn's disease	0.000104	0.00113	CcSEcCtD
Sunitinib—YES1—lymph node—Crohn's disease	0.000103	0.000971	CbGeAlD
Sunitinib—STK10—lymph node—Crohn's disease	0.000102	0.000962	CbGeAlD
Sunitinib—TAOK3—lymph node—Crohn's disease	0.000102	0.000959	CbGeAlD
Sunitinib—PDGFRA—lymph node—Crohn's disease	0.000101	0.000953	CbGeAlD
Sunitinib—Bradycardia—Prednisone—Crohn's disease	9.94e-05	0.00108	CcSEcCtD
Sunitinib—Diarrhoea—Azathioprine—Crohn's disease	9.85e-05	0.00107	CcSEcCtD
Sunitinib—Haemoglobin—Prednisone—Crohn's disease	9.81e-05	0.00107	CcSEcCtD
Sunitinib—Haemorrhage—Prednisone—Crohn's disease	9.76e-05	0.00106	CcSEcCtD
Sunitinib—Hypersensitivity—Mesalazine—Crohn's disease	9.66e-05	0.00105	CcSEcCtD
Sunitinib—Connective tissue disorder—Prednisone—Crohn's disease	9.6e-05	0.00104	CcSEcCtD
Sunitinib—Dizziness—Azathioprine—Crohn's disease	9.52e-05	0.00103	CcSEcCtD
Sunitinib—Asthenia—Mesalazine—Crohn's disease	9.41e-05	0.00102	CcSEcCtD
Sunitinib—Pruritus—Mesalazine—Crohn's disease	9.28e-05	0.00101	CcSEcCtD
Sunitinib—CHEK2—Danazol—Prednisone—Crohn's disease	9.21e-05	0.0424	CbGdCrCtD
Sunitinib—Vomiting—Azathioprine—Crohn's disease	9.15e-05	0.000994	CcSEcCtD
Sunitinib—MAP2K5—lymph node—Crohn's disease	9.14e-05	0.000859	CbGeAlD
Sunitinib—KDR—lymph node—Crohn's disease	9.14e-05	0.000859	CbGeAlD
Sunitinib—Eye disorder—Prednisone—Crohn's disease	9.13e-05	0.000991	CcSEcCtD
Sunitinib—Rash—Azathioprine—Crohn's disease	9.08e-05	0.000985	CcSEcCtD
Sunitinib—Dermatitis—Azathioprine—Crohn's disease	9.07e-05	0.000984	CcSEcCtD
Sunitinib—Flushing—Prednisone—Crohn's disease	9.06e-05	0.000984	CcSEcCtD
Sunitinib—Headache—Azathioprine—Crohn's disease	9.02e-05	0.000979	CcSEcCtD
Sunitinib—Diarrhoea—Mesalazine—Crohn's disease	8.97e-05	0.000974	CcSEcCtD
Sunitinib—CSF1R—lymph node—Crohn's disease	8.92e-05	0.000839	CbGeAlD
Sunitinib—ABCG2—mammalian vulva—Crohn's disease	8.87e-05	0.000835	CbGeAlD
Sunitinib—Angiopathy—Prednisone—Crohn's disease	8.86e-05	0.000962	CcSEcCtD
Sunitinib—Immune system disorder—Prednisone—Crohn's disease	8.82e-05	0.000957	CcSEcCtD
Sunitinib—Arrhythmia—Prednisone—Crohn's disease	8.72e-05	0.000947	CcSEcCtD
Sunitinib—Dizziness—Mesalazine—Crohn's disease	8.67e-05	0.000941	CcSEcCtD
Sunitinib—Alopecia—Prednisone—Crohn's disease	8.63e-05	0.000937	CcSEcCtD
Sunitinib—Mental disorder—Prednisone—Crohn's disease	8.55e-05	0.000929	CcSEcCtD
Sunitinib—Nausea—Azathioprine—Crohn's disease	8.55e-05	0.000928	CcSEcCtD
Sunitinib—Erythema—Prednisone—Crohn's disease	8.5e-05	0.000923	CcSEcCtD
Sunitinib—Malnutrition—Prednisone—Crohn's disease	8.5e-05	0.000923	CcSEcCtD
Sunitinib—Vomiting—Mesalazine—Crohn's disease	8.34e-05	0.000905	CcSEcCtD
Sunitinib—Rash—Mesalazine—Crohn's disease	8.27e-05	0.000897	CcSEcCtD
Sunitinib—Dermatitis—Mesalazine—Crohn's disease	8.26e-05	0.000897	CcSEcCtD
Sunitinib—Headache—Mesalazine—Crohn's disease	8.21e-05	0.000892	CcSEcCtD
Sunitinib—KIT—lymph node—Crohn's disease	8.1e-05	0.000762	CbGeAlD
Sunitinib—PDGFRB—lymph node—Crohn's disease	7.91e-05	0.000744	CbGeAlD
Sunitinib—Anaemia—Prednisone—Crohn's disease	7.86e-05	0.000853	CcSEcCtD
Sunitinib—Nausea—Mesalazine—Crohn's disease	7.79e-05	0.000845	CcSEcCtD
Sunitinib—Angioedema—Prednisone—Crohn's disease	7.77e-05	0.000843	CcSEcCtD
Sunitinib—Convulsion—Prednisone—Crohn's disease	7.36e-05	0.0008	CcSEcCtD
Sunitinib—Hypertension—Prednisone—Crohn's disease	7.34e-05	0.000797	CcSEcCtD
Sunitinib—Myalgia—Prednisone—Crohn's disease	7.24e-05	0.000786	CcSEcCtD
Sunitinib—Arthralgia—Prednisone—Crohn's disease	7.24e-05	0.000786	CcSEcCtD
Sunitinib—CYP3A5—digestive system—Crohn's disease	7.22e-05	0.000679	CbGeAlD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	7.19e-05	0.00078	CcSEcCtD
Sunitinib—Oedema—Prednisone—Crohn's disease	6.94e-05	0.000753	CcSEcCtD
Sunitinib—Infection—Prednisone—Crohn's disease	6.89e-05	0.000748	CcSEcCtD
Sunitinib—Shock—Prednisone—Crohn's disease	6.83e-05	0.000741	CcSEcCtD
Sunitinib—Nervous system disorder—Prednisone—Crohn's disease	6.8e-05	0.000739	CcSEcCtD
Sunitinib—Skin disorder—Prednisone—Crohn's disease	6.74e-05	0.000732	CcSEcCtD
Sunitinib—Anorexia—Prednisone—Crohn's disease	6.61e-05	0.000718	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Prednisone—Crohn's disease	6.32e-05	0.000686	CcSEcCtD
Sunitinib—ABCC4—lymph node—Crohn's disease	6.3e-05	0.000592	CbGeAlD
Sunitinib—Insomnia—Prednisone—Crohn's disease	6.27e-05	0.000681	CcSEcCtD
Sunitinib—Paraesthesia—Prednisone—Crohn's disease	6.23e-05	0.000676	CcSEcCtD
Sunitinib—Dyspepsia—Prednisone—Crohn's disease	6.11e-05	0.000663	CcSEcCtD
Sunitinib—ABCC2—lymph node—Crohn's disease	6.1e-05	0.000573	CbGeAlD
Sunitinib—Decreased appetite—Prednisone—Crohn's disease	6.03e-05	0.000655	CcSEcCtD
Sunitinib—Fatigue—Prednisone—Crohn's disease	5.98e-05	0.000649	CcSEcCtD
Sunitinib—Constipation—Prednisone—Crohn's disease	5.93e-05	0.000644	CcSEcCtD
Sunitinib—Gastrointestinal pain—Prednisone—Crohn's disease	5.67e-05	0.000616	CcSEcCtD
Sunitinib—Body temperature increased—Prednisone—Crohn's disease	5.48e-05	0.000595	CcSEcCtD
Sunitinib—Abdominal pain—Prednisone—Crohn's disease	5.48e-05	0.000595	CcSEcCtD
Sunitinib—CYP3A4—digestive system—Crohn's disease	5.42e-05	0.00051	CbGeAlD
Sunitinib—Hypersensitivity—Prednisone—Crohn's disease	5.11e-05	0.000555	CcSEcCtD
Sunitinib—ABCB1—epithelium—Crohn's disease	5.04e-05	0.000474	CbGeAlD
Sunitinib—KCNH2—lymph node—Crohn's disease	5e-05	0.00047	CbGeAlD
Sunitinib—Asthenia—Prednisone—Crohn's disease	4.98e-05	0.00054	CcSEcCtD
Sunitinib—Pruritus—Prednisone—Crohn's disease	4.91e-05	0.000533	CcSEcCtD
Sunitinib—Diarrhoea—Prednisone—Crohn's disease	4.75e-05	0.000515	CcSEcCtD
Sunitinib—Dizziness—Prednisone—Crohn's disease	4.59e-05	0.000498	CcSEcCtD
Sunitinib—ABCG2—lymph node—Crohn's disease	4.45e-05	0.000418	CbGeAlD
Sunitinib—Vomiting—Prednisone—Crohn's disease	4.41e-05	0.000479	CcSEcCtD
Sunitinib—ABCB1—mammalian vulva—Crohn's disease	4.38e-05	0.000412	CbGeAlD
Sunitinib—Rash—Prednisone—Crohn's disease	4.37e-05	0.000475	CcSEcCtD
Sunitinib—Dermatitis—Prednisone—Crohn's disease	4.37e-05	0.000474	CcSEcCtD
Sunitinib—Headache—Prednisone—Crohn's disease	4.35e-05	0.000472	CcSEcCtD
Sunitinib—Nausea—Prednisone—Crohn's disease	4.12e-05	0.000447	CcSEcCtD
Sunitinib—ABCB1—lymphoid tissue—Crohn's disease	3.89e-05	0.000365	CbGeAlD
Sunitinib—ABCB1—digestive system—Crohn's disease	3.84e-05	0.000361	CbGeAlD
Sunitinib—ABCB1—lymph node—Crohn's disease	2.19e-05	0.000206	CbGeAlD
Sunitinib—MAP3K7—Innate Immune System—IL6—Crohn's disease	1.64e-06	9.97e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—JAK2—Crohn's disease	1.64e-06	9.92e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL1B—Crohn's disease	1.64e-06	9.91e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL1B—Crohn's disease	1.64e-06	9.91e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—CD4—Crohn's disease	1.64e-06	9.91e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TYK2—Crohn's disease	1.63e-06	9.9e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—JAK2—Crohn's disease	1.63e-06	9.9e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—JAK2—Crohn's disease	1.63e-06	9.89e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling by GPCR—IL6—Crohn's disease	1.63e-06	9.89e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—CXCL8—Crohn's disease	1.63e-06	9.88e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—IL6—Crohn's disease	1.63e-06	9.86e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—PTGS2—Crohn's disease	1.62e-06	9.84e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—TYK2—Crohn's disease	1.61e-06	9.76e-06	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—IL6—Crohn's disease	1.61e-06	9.75e-06	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—IL6—Crohn's disease	1.61e-06	9.75e-06	CbGpPWpGaD
Sunitinib—JAK2—GPCR downstream signaling—CXCL8—Crohn's disease	1.61e-06	9.73e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IFNG—Crohn's disease	1.6e-06	9.71e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—TYK2—Crohn's disease	1.6e-06	9.7e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—JAK2—Crohn's disease	1.6e-06	9.69e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—JAK2—Crohn's disease	1.6e-06	9.69e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SMAD3—Crohn's disease	1.6e-06	9.67e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—JAK2—Crohn's disease	1.59e-06	9.66e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SMAD3—Crohn's disease	1.59e-06	9.62e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TYK2—Crohn's disease	1.58e-06	9.58e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—CXCL8—Crohn's disease	1.57e-06	9.53e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL2RA—Crohn's disease	1.57e-06	9.52e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IFNG—Crohn's disease	1.56e-06	9.48e-06	CbGpPWpGaD
Sunitinib—FGFR1—Innate Immune System—IL6—Crohn's disease	1.56e-06	9.46e-06	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—IL6—Crohn's disease	1.56e-06	9.46e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—JAK2—Crohn's disease	1.56e-06	9.44e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Innate Immune System—IL6—Crohn's disease	1.56e-06	9.43e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL1B—Crohn's disease	1.55e-06	9.41e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—CD4—Crohn's disease	1.55e-06	9.4e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL1B—Crohn's disease	1.55e-06	9.38e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—CD4—Crohn's disease	1.55e-06	9.38e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—CD4—Crohn's disease	1.55e-06	9.38e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TYK2—Crohn's disease	1.54e-06	9.34e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—PTGS2—Crohn's disease	1.54e-06	9.34e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—PTGS2—Crohn's disease	1.54e-06	9.31e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—JAK2—Crohn's disease	1.54e-06	9.31e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—STAT3—Crohn's disease	1.54e-06	9.31e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL2RA—Crohn's disease	1.53e-06	9.29e-06	CbGpPWpGaD
Sunitinib—IRAK4—Immune System—IL6—Crohn's disease	1.53e-06	9.29e-06	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—IL6—Crohn's disease	1.53e-06	9.28e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.53e-06	9.27e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—TYK2—Crohn's disease	1.53e-06	9.27e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—JAK2—Crohn's disease	1.53e-06	9.26e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—CXCL8—Crohn's disease	1.53e-06	9.25e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—IL6—Crohn's disease	1.52e-06	9.23e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SMAD3—Crohn's disease	1.52e-06	9.19e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—CXCL8—Crohn's disease	1.51e-06	9.18e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—CD4—Crohn's disease	1.51e-06	9.15e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IFNG—Crohn's disease	1.51e-06	9.14e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—JAK2—Crohn's disease	1.51e-06	9.14e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—CXCL8—Crohn's disease	1.5e-06	9.12e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IFNG—Crohn's disease	1.5e-06	9.09e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Immune System—IL6—Crohn's disease	1.49e-06	9.03e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—TYK2—Crohn's disease	1.49e-06	9.01e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—STAT3—Crohn's disease	1.48e-06	9e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—IL6—Crohn's disease	1.48e-06	8.97e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TYK2—Crohn's disease	1.48e-06	8.96e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL2RA—Crohn's disease	1.48e-06	8.95e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—JAK2—Crohn's disease	1.47e-06	8.91e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL2RA—Crohn's disease	1.47e-06	8.9e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—CXCL8—Crohn's disease	1.46e-06	8.84e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—CXCL8—Crohn's disease	1.46e-06	8.84e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—CXCL8—Crohn's disease	1.46e-06	8.84e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—STAT3—Crohn's disease	1.46e-06	8.83e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—CD4—Crohn's disease	1.46e-06	8.82e-06	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—IL6—Crohn's disease	1.46e-06	8.82e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—CD4—Crohn's disease	1.45e-06	8.78e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling by GPCR—IL6—Crohn's disease	1.44e-06	8.73e-06	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—IL6—Crohn's disease	1.44e-06	8.73e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Innate Immune System—IL6—Crohn's disease	1.44e-06	8.71e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IFNG—Crohn's disease	1.43e-06	8.68e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL1B—Crohn's disease	1.43e-06	8.66e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—CD4—Crohn's disease	1.43e-06	8.66e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—CXCL8—Crohn's disease	1.42e-06	8.62e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—PTGS2—Crohn's disease	1.42e-06	8.6e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—JAK2—Crohn's disease	1.42e-06	8.59e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TYK2—Crohn's disease	1.42e-06	8.59e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—STAT3—Crohn's disease	1.41e-06	8.57e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—TYK2—Crohn's disease	1.41e-06	8.56e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—JAK2—Crohn's disease	1.41e-06	8.55e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL2RA—Crohn's disease	1.4e-06	8.51e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Innate Immune System—IL6—Crohn's disease	1.4e-06	8.5e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—STAT3—Crohn's disease	1.4e-06	8.46e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL1B—Crohn's disease	1.4e-06	8.45e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—CD4—Crohn's disease	1.39e-06	8.45e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—STAT3—Crohn's disease	1.39e-06	8.44e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—PTGS2—Crohn's disease	1.38e-06	8.39e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—CD4—Crohn's disease	1.38e-06	8.39e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—STAT3—Crohn's disease	1.38e-06	8.36e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—STAT3—Crohn's disease	1.37e-06	8.31e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—STAT3—Crohn's disease	1.37e-06	8.31e-06	CbGpPWpGaD
Sunitinib—PTK2B—Immune System—IL6—Crohn's disease	1.37e-06	8.28e-06	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—IL6—Crohn's disease	1.36e-06	8.25e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—JAK2—Crohn's disease	1.35e-06	8.2e-06	CbGpPWpGaD
Sunitinib—FYN—Innate Immune System—IL6—Crohn's disease	1.35e-06	8.19e-06	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—IL6—Crohn's disease	1.35e-06	8.16e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TYK2—Crohn's disease	1.35e-06	8.15e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL1B—Crohn's disease	1.34e-06	8.15e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Innate Immune System—IL6—Crohn's disease	1.34e-06	8.15e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—CD4—Crohn's disease	1.34e-06	8.15e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL1B—Crohn's disease	1.34e-06	8.11e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—CD4—Crohn's disease	1.34e-06	8.1e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—PTGS2—Crohn's disease	1.33e-06	8.09e-06	CbGpPWpGaD
Sunitinib—BLK—Immune System—IL6—Crohn's disease	1.33e-06	8.08e-06	CbGpPWpGaD
Sunitinib—FGR—Immune System—IL6—Crohn's disease	1.33e-06	8.05e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—PTGS2—Crohn's disease	1.33e-06	8.04e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—STAT3—Crohn's disease	1.31e-06	7.91e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—STAT3—Crohn's disease	1.3e-06	7.89e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—STAT3—Crohn's disease	1.3e-06	7.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TYK2—Crohn's disease	1.29e-06	7.81e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—STAT3—Crohn's disease	1.29e-06	7.81e-06	CbGpPWpGaD
Sunitinib—JAK2—Innate Immune System—IL6—Crohn's disease	1.29e-06	7.79e-06	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—IL6—Crohn's disease	1.28e-06	7.78e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—JAK2—Crohn's disease	1.28e-06	7.77e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL1B—Crohn's disease	1.28e-06	7.75e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—CD4—Crohn's disease	1.28e-06	7.74e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—PTGS2—Crohn's disease	1.27e-06	7.69e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TYK2—Crohn's disease	1.27e-06	7.67e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TYK2—Crohn's disease	1.27e-06	7.67e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—STAT3—Crohn's disease	1.27e-06	7.67e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—STAT3—Crohn's disease	1.26e-06	7.66e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—JAK2—Crohn's disease	1.25e-06	7.55e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—CXCL8—Crohn's disease	1.23e-06	7.48e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—JAK2—Crohn's disease	1.23e-06	7.45e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—STAT3—Crohn's disease	1.22e-06	7.38e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—STAT3—Crohn's disease	1.21e-06	7.33e-06	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—IL6—Crohn's disease	1.21e-06	7.33e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—JAK2—Crohn's disease	1.21e-06	7.32e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—JAK2—Crohn's disease	1.21e-06	7.32e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TYK2—Crohn's disease	1.2e-06	7.28e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—STAT3—Crohn's disease	1.2e-06	7.28e-06	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—IL6—Crohn's disease	1.2e-06	7.27e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TYK2—Crohn's disease	1.2e-06	7.26e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—STAT3—Crohn's disease	1.2e-06	7.26e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—STAT3—Crohn's disease	1.2e-06	7.26e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—FADS1—Crohn's disease	1.19e-06	7.23e-06	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.19e-06	7.21e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—STAT3—Crohn's disease	1.17e-06	7.11e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—STAT3—Crohn's disease	1.17e-06	7.11e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—CXCL8—Crohn's disease	1.17e-06	7.1e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—STAT3—Crohn's disease	1.17e-06	7.09e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—JAK2—Crohn's disease	1.15e-06	6.95e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—JAK2—Crohn's disease	1.14e-06	6.93e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—STAT3—Crohn's disease	1.14e-06	6.93e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—CXCL8—Crohn's disease	1.14e-06	6.89e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—STAT3—Crohn's disease	1.13e-06	6.83e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—CXCL8—Crohn's disease	1.12e-06	6.8e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—STAT3—Crohn's disease	1.12e-06	6.79e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GPX4—Crohn's disease	1.12e-06	6.77e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TYK2—Crohn's disease	1.11e-06	6.71e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—STAT3—Crohn's disease	1.11e-06	6.71e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—CXCL8—Crohn's disease	1.1e-06	6.68e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—CXCL8—Crohn's disease	1.1e-06	6.68e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling by GPCR—IL6—Crohn's disease	1.08e-06	6.55e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TYK2—Crohn's disease	1.08e-06	6.54e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—STAT3—Crohn's disease	1.08e-06	6.54e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GCKR—Crohn's disease	1.08e-06	6.53e-06	CbGpPWpGaD
Sunitinib—YES1—Immune System—IL6—Crohn's disease	1.07e-06	6.5e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—STAT3—Crohn's disease	1.07e-06	6.49e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—JAK2—Crohn's disease	1.06e-06	6.4e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—CXCL8—Crohn's disease	1.05e-06	6.34e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—CXCL8—Crohn's disease	1.04e-06	6.32e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TYK2—Crohn's disease	1.04e-06	6.31e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—STAT3—Crohn's disease	1.04e-06	6.31e-06	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—IL6—Crohn's disease	1.04e-06	6.28e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TYK2—Crohn's disease	1.04e-06	6.27e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—STAT3—Crohn's disease	1.04e-06	6.27e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ALB—Crohn's disease	1.03e-06	6.24e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—JAK2—Crohn's disease	1.03e-06	6.24e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ALB—Crohn's disease	1.02e-06	6.19e-06	CbGpPWpGaD
Sunitinib—IRAK1—Immune System—IL6—Crohn's disease	1.02e-06	6.16e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—JAK2—Crohn's disease	9.93e-07	6.02e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—STAT3—Crohn's disease	9.93e-07	6.02e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TYK2—Crohn's disease	9.9e-07	6e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—STAT3—Crohn's disease	9.89e-07	6e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—JAK2—Crohn's disease	9.88e-07	5.99e-06	CbGpPWpGaD
Sunitinib—TYK2—Immune System—IL6—Crohn's disease	9.88e-07	5.98e-06	CbGpPWpGaD
Sunitinib—FGFR2—Immune System—IL6—Crohn's disease	9.75e-07	5.91e-06	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—IL6—Crohn's disease	9.73e-07	5.89e-06	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—IL6—Crohn's disease	9.64e-07	5.84e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—CXCL8—Crohn's disease	9.64e-07	5.84e-06	CbGpPWpGaD
Sunitinib—KIT—Immune System—IL6—Crohn's disease	9.58e-07	5.8e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Immune System—IL6—Crohn's disease	9.58e-07	5.8e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—STAT3—Crohn's disease	9.42e-07	5.71e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—CXCL8—Crohn's disease	9.4e-07	5.7e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling by GPCR—IL6—Crohn's disease	9.16e-07	5.55e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—STAT3—Crohn's disease	9.14e-07	5.54e-06	CbGpPWpGaD
Sunitinib—TYK2—Disease—IL6—Crohn's disease	9.12e-07	5.53e-06	CbGpPWpGaD
Sunitinib—FGFR1—Immune System—IL6—Crohn's disease	9.09e-07	5.51e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Immune System—IL6—Crohn's disease	9.07e-07	5.49e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—CXCL8—Crohn's disease	9.06e-07	5.49e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—STAT3—Crohn's disease	9.03e-07	5.47e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—CXCL8—Crohn's disease	9.02e-07	5.46e-06	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—PTGS2—Crohn's disease	9.01e-07	5.46e-06	CbGpPWpGaD
Sunitinib—FGFR2—Disease—IL6—Crohn's disease	9.01e-07	5.46e-06	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—PTGS2—Crohn's disease	8.94e-07	5.41e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—STAT3—Crohn's disease	8.87e-07	5.37e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—STAT3—Crohn's disease	8.87e-07	5.37e-06	CbGpPWpGaD
Sunitinib—KIT—Disease—IL6—Crohn's disease	8.85e-07	5.36e-06	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—IL6—Crohn's disease	8.83e-07	5.35e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—CXCL8—Crohn's disease	8.62e-07	5.22e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—IL6—Crohn's disease	8.57e-07	5.19e-06	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—IL6—Crohn's disease	8.51e-07	5.16e-06	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—IL6—Crohn's disease	8.45e-07	5.12e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—STAT3—Crohn's disease	8.42e-07	5.1e-06	CbGpPWpGaD
Sunitinib—FGFR1—Disease—IL6—Crohn's disease	8.39e-07	5.09e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—STAT3—Crohn's disease	8.39e-07	5.09e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—IL6—Crohn's disease	8.37e-07	5.07e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Immune System—IL6—Crohn's disease	8.37e-07	5.07e-06	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—IL6—Crohn's disease	8.2e-07	4.97e-06	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—IL6—Crohn's disease	8.2e-07	4.97e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—IL6—Crohn's disease	8.19e-07	4.96e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Immune System—IL6—Crohn's disease	8.17e-07	4.95e-06	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—IL6—Crohn's disease	7.99e-07	4.84e-06	CbGpPWpGaD
Sunitinib—FYN—Immune System—IL6—Crohn's disease	7.87e-07	4.77e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Immune System—IL6—Crohn's disease	7.83e-07	4.75e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—STAT3—Crohn's disease	7.75e-07	4.7e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—IL6—Crohn's disease	7.73e-07	4.68e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—STAT3—Crohn's disease	7.56e-07	4.58e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—IL6—Crohn's disease	7.54e-07	4.57e-06	CbGpPWpGaD
Sunitinib—JAK2—Immune System—IL6—Crohn's disease	7.49e-07	4.54e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—Crohn's disease	7.38e-07	4.47e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—STAT3—Crohn's disease	7.29e-07	4.42e-06	CbGpPWpGaD
Sunitinib—FYN—Disease—IL6—Crohn's disease	7.27e-07	4.41e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—STAT3—Crohn's disease	7.25e-07	4.39e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—IL6—Crohn's disease	7.23e-07	4.38e-06	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—IL6—Crohn's disease	6.94e-07	4.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—STAT3—Crohn's disease	6.93e-07	4.2e-06	CbGpPWpGaD
Sunitinib—JAK2—Disease—IL6—Crohn's disease	6.91e-07	4.19e-06	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—IL6—Crohn's disease	6.58e-07	3.99e-06	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—PTGS2—Crohn's disease	6.46e-07	3.91e-06	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—IL6—Crohn's disease	6.39e-07	3.87e-06	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—IL6—Crohn's disease	6.31e-07	3.82e-06	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—IL6—Crohn's disease	6.19e-07	3.75e-06	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—IL6—Crohn's disease	6.19e-07	3.75e-06	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—IL6—Crohn's disease	5.88e-07	3.56e-06	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—IL6—Crohn's disease	5.86e-07	3.55e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—Crohn's disease	5.57e-07	3.38e-06	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—IL6—Crohn's disease	5.41e-07	3.28e-06	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—IL6—Crohn's disease	5.28e-07	3.2e-06	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—IL6—Crohn's disease	5.09e-07	3.09e-06	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—IL6—Crohn's disease	5.06e-07	3.07e-06	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—PTGS2—Crohn's disease	4.87e-07	2.95e-06	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—IL6—Crohn's disease	4.84e-07	2.93e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—Crohn's disease	3.43e-07	2.08e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—PTGS2—Crohn's disease	3e-07	1.82e-06	CbGpPWpGaD
